SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Market participants are weighing geopolitical tensions and rising bond yields against high-profile trade optimism following summit meetings in Beijing. Community discussion is heavily divided, with some traders anticipating a technical correction or 'V-shaped' recovery, while others express caution over stretched equity valuations and potential volatility surrounding monthly options expiration.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

Market participants are actively debating the sustainability of current highs, with intense focus on the AI sector's massive capital expenditure and the broader implications of rising bond yields. Community discussion is dominated by a divide between those betting on continued momentum driven by corporate earnings and those positioning for potential volatility around options expiration.

Figma, Inc. is an AI-powered digital design and product development platform. The firm offers tools for teams to collaborate on the entire lifecycle of software creation. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figma is trending following a strong quarterly earnings report featuring revenue growth that beat analyst expectations and raised full-year guidance, fueled by accelerating enterprise adoption of its AI-powered features. Community sentiment is heavily focused on a potential short squeeze, with investors highlighting significant short interest and arguing that the companys strong net dollar retention and essential role in design workflows prove its long-term value despite broader market concerns about AI competition.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

Direxion Daily Semiconductor Bear 3X Shares is trending as traders debate the sustainability of the semiconductor rally, with many expressing deep frustration over the asset's volatility decay and the aggressive market momentum driving chip valuations to historic highs. The conversation is dominated by intense disagreement between retail bears expecting a market correction tied to geopolitical tensions and macroeconomic data, and bulls who remain convinced that AI-related capital expenditure will continue to fuel industry growth.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is facing significant selling pressure and volatility as investors weigh the impact of an ongoing OpenAI-related legal battle against the company's broader AI integration and cloud infrastructure strategy. While community sentiment remains divided between those viewing the current price weakness as a long-term accumulation opportunity and those frustrated by its relative underperformance compared to other mega-cap tech, active discussions highlight a rotation toward software monetization and potential catalysts from upcoming legal proceedings.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is trending due to renewed optimism regarding chip sales in China, fueling investor anticipation as the company nears its upcoming earnings report. The community remains deeply divided, with bulls pointing to the stock's dominant AI market position and potential for continued growth, while bears express concerns over its massive market capitalization and the sustainability of current AI-driven valuations.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Dallas, TX.

United States Antimony Corp.

United States Antimony Corp. (UAMY) is facing increased volatility as investors react to a disappointing first-quarter earnings report, which highlighted significant net losses and delayed production timelines at its Montana smelter. Despite these operational setbacks, the community remains deeply divided, with many long-term shareholders advocating to 'buy the fear' based on strong government grant milestones, domestic supply chain importance, and the significant future value of its tungsten assets.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is experiencing heightened investor interest ahead of a highly anticipated plenary presentation at the AUA annual meeting, where the company will share updated, extended follow-up data from its pivotal Phase 3 trial. The community is actively discussing the potential for this data to solidify the drug's role as a practice-changing standard of care, with sentiment bolstered by strong institutional backing and speculation regarding the asset's commercial value in the large localized prostate cancer market.

Robo.ai, Inc. engages in the design and development of smart electric vehicles. It aims to integrate avant-garde design, life-style personalization, IoT connectivity, and autonomous driving technology. The company was founded in 2016 and is headquartered in Dubai, United Arab Emirates.

Robo.ai Inc. - Ordinary Shares - Class B

Robo.ai Inc.

Robo.ai Inc. ($AIIO) is trending as retail traders leverage extreme short interest and high borrow rates to fuel intense volatility and speculative price action. While some community members are highlighting the stock's recent multi-day rally and potential for a short squeeze, others remain cautious of the rapid swings and high-risk nature of these parabolic moves in low-float stocks.

Gemini Space Station, Inc. is a holding company, which offers a mobile and web based crypto asset exchange platform, proprietary wallet infrastructure and custody solutions, over-the-counter trading solutions tailored to institutions and professionals, a digital art auction platform, a proprietary United States dollar backed stablecoin, and a credit card product that offers crypto asset rewards on customer purchases. The company was founded by Tyler Winklevoss and Cameron Winklevoss in 2014 and is headquartered in New York, NY.

Gemini Space Station Inc. - Ordinary Shares- Class A

Gemini Space Station

Gemini Space Station is rallying following a $100 million strategic investment from the Winklevoss Capital Fund, paired with better-than-expected quarterly results. The community is actively discussing potential for a short squeeze given high short interest, while some remain cautious due to ongoing legal scrutiny and the stock's significant decline since its IPO.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Kyntra Bio (KYNB) Q1 2026 Earnings Transcript

@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...

Kyntra Bio (KYNB) Reports Q1 Loss, Tops Revenue Estimates

Kyntra Bio (KYNB) delivered earnings and revenue surprises of -11.48% and +140.39%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Beam Therapeutics Inc. (BEAM) Reports Q1 Loss, Beats Revenue Estimates

Beam Therapeutics (BEAM) delivered earnings and revenue surprises of -4.60% and +52.44%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Kyntra Bio (KYNB) Upgraded to Buy: Here's What You Should Know

Kyntra Bio (KYNB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Kyntra Bio (KYNB) Q4 2025 Earnings Call Transcript

Monte Rosa Therapeutics (GLUE) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Monte Rosa Therapeutics (GLUE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Septerna, Inc. (SEPN) Reports Q4 Loss, Tops Revenue Estimates

Septerna, Inc. (SEPN) delivered earnings and revenue surprises of -5.50% and +17.98%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Kyntra Bio (KYNB) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

Kyntra Bio (KYNB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Kyntra Bio, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993, and is headquartered in San Francisco, CA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	-$3.27	--	--	N/A
Q1 '26	-$3.36	-$3.76	-12.07%	MISSED
Q4 '25	-$3.88	-$3.51	9.65%	BEAT
Q3 '25	-$4.01	$49.61	1338.08%	BEAT
Q2 '25	-$2.30	-$1.88	18.38%	BEAT

KYNB
Kyntra Bio Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q1 '26

Historical Earnings

Latest KYNB News

KYNBKyntra Bio Inc.